Repositorio Dspace

Contact pathway in surgical and transcatheter aortic valve replacement

Mostrar el registro sencillo del ítem

dc.contributor.author de-la-Morena-Barrio, María-Eugenia
dc.contributor.author Corral, Javier
dc.contributor.author López-García, Cecilia
dc.contributor.author Jiménez-Díaz, Víctor-Alfonso
dc.contributor.author Miñano, Antonia
dc.contributor.author Juan-Salvadores, Pablo
dc.contributor.author Esteve-Pastor, María-Asunción
dc.contributor.author Baz-Alonso, José-Antonio
dc.contributor.author Rubio, Ana-María
dc.contributor.author Sarabia-Tirado, Francisco
dc.contributor.author García-Navarro, Miguel
dc.contributor.author García-Lara, Juan
dc.contributor.author Marín, Francisco
dc.contributor.author Marín, Francisco
dc.contributor.author Vicente, Vicente
dc.contributor.author Pinar-Bermúdez, Eduardo
dc.contributor.author Pinar-Bermúdez, Eduardo
dc.contributor.author Cánovas-López, Sergio-J
dc.contributor.author de-la-Morena-Valenzuela, Gonzalo
dc.date.accessioned 2025-11-21T08:44:13Z
dc.date.available 2025-11-21T08:44:13Z
dc.date.issued 2022-07
dc.identifier.citation De La Morena-Barrio ME, Corral J, López-García C, Jiménez-Díaz VA, Miñano A, Juan-Salvadores P, et al. Contact pathway in surgical and transcatheter aortic valve replacement. Front Cardiovasc Med. 22 de julio de 2022;9:887664.
dc.identifier.issn 2297-055X
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/21939
dc.description.abstract BACKGROUND: Aortic valve replacement is the gold standard treatment for severe symptomatic aortic stenosis, but thrombosis of bioprosthetic valves (PVT) remains a concern. OBJECTIVE: To analyze the factors involved in the contact pathway during aortic valve replacement and to assess their impact on the development of thromboembolic complications. METHODS: The study was conducted in 232 consecutive patients who underwent: transcatheter aortic valve replacement (TAVR, N = 155), and surgical valve replacement (SAVR, N = 77) (MUVITAVI project). Demographic and clinical data, outcomes including a combined end point (CEP) of thrombotic events, and imaging controls were recruited. Samples were collected 24 h before and 48 h after valve replacement. FXII, FXI and (pre)kallikrein were evaluated by Western Blot and specific ELISA with nanobodies. RESULTS: The CEP of thrombotic events was reached by 19 patients: 13 patients presented systemic embolic events and 6 patients subclinical PVT. Valve replacement did not cause FXII activation or generation of kallikrein. There was a significant reduction of FXI levels associated with the procedure, which was statistically more pronounced in SAVR than in TAVR. Cases with reductions of FXI below 80% of basal values had a lower incidence of embolic events during the procedure than patients in whom FXI increased above 150%: 2.7 vs. 16.7%; p: 0.04. CONCLUSION: TAVR or SAVR did not significantly activate the contact pathway. A significant reduction of FXI, was observed, particularly in SAVR, associated with lower incidence of thrombotic events. These results encourage evaluating the usefulness and safety of FXI-directed antithrombotic treatments in these patients.
dc.language.iso eng
dc.publisher FRONTIERS MEDIA SA
dc.rights Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional
dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/4.0/es/  *
dc.title Contact pathway in surgical and transcatheter aortic valve replacement
dc.type info:eu-repo/semantics/article
dc.identifier.pmid 35935621
dc.relation.publisherversion https://www.frontiersin.org/articles/10.3389/fcvm.2022.887664/full
dc.identifier.doi 10.3389/fcvm.2022.887664
dc.journal.title Frontiers in Cardiovascular Medicine


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta